v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Total revenue, net $ 45,689 $ 20,923 $ 71,907 $ 29,905
Cost and operating expenses:        
Cost of sales (20,468) (24,445) (45,036) (42,396)
Research and development expenses, net (27,898) (27,430) (49,108) (54,164)
Selling, general and administrative expenses (41,161) (30,265) (81,114) (59,802)
Loss from operations (43,838) (61,217) (103,351) (126,457)
Other income (expense):        
Other income, net 181 135 281 262
Foreign exchange gains (losses), net 460 1,499 (2,207) 2,680
Interest income 1,877 5,234 4,346 11,371
Interest expense, net 2,674 6,829 (8,450) (3,314)
Total other income (expenses), net 5,192 13,697 (6,030) 10,999
Net loss before income tax (38,646) (47,520) (109,381) (115,458)
Income tax expense (465) (397) (1,328) (2,623)
Net loss (39,111) (47,917) (110,709) (118,081)
Other comprehensive (loss) income:        
Foreign currency exchange translation adjustment 538 18,990 (592) 29,658
Unrealized holding (losses) gains on available-for-sale debt securities, net of tax of $0, $0, $0 and $0, respectively (12) (22) (153) 378
Total other comprehensive income (loss), net of tax 526 18,968 (745) 30,036
Total comprehensive loss $ (38,585) $ (28,949) $ (111,454) $ (88,045)
Basic net loss per ordinary share (in usd per share) $ (0.15) $ (0.18) $ (0.42) $ (0.44)
Diluted net loss per ordinary share (in usd per share) $ (0.15) $ (0.18) $ (0.42) $ (0.44)
Weighted-average basic ordinary shares (in shares) 266,158,829 266,141,411 266,151,170 266,134,021
Weighted-average diluted ordinary shares (in shares) 266,158,829 266,141,411 266,151,170 266,134,021
Product revenue, net        
Total revenue, net $ 45,672 $ 20,923 $ 71,890 $ 29,905
License revenue        
Total revenue, net $ 17 $ 0 $ 17 $ 0